School of Medicine Proposal Development Office

The Proposal Development Office (PDO) enables Stanford Medicine faculty to pursue transformative biomedical research. We provide expert consultation on grant proposal strategy, proposal management and facilitation, grant writing and editing, and streamlined proposal administrative support. We also lead initiatives in the School of Medicine that increase institutional competitiveness and enable strategic research growth. 

Based in the School of Medicine Research Office, we are uniquely positioned to support teams of Stanford Medicine researchers pursuing interdisciplinary and cross-cutting funding opportunities. Our current priority areas include large, complex, and strategic proposals and early-career faculty research grants.

PDO interview with Stanford's first ARPA-H awardee - Dr. Mark Skylar-Scott

Curious about ARPA-H funding mechanism and have questions about how to apply and secure funding? PD specialist, Dr. Lee Fradkin, talks to Dr. Mark Skylar-Scott, the first ever recipient of ARPA-H funding at Stanford, to answer some common questions and provide an overview. Review the guide for developing a clear program concept for ARPA-H proposers.

242+ proposals

The PDO has assisted faculty from 27 School of Medicine departments submit more than 242 proposals.

150+ PIs

The PDO has supported more than 150 faculty members from across the School of Medicine.


The PDO has helped faculty secure over $613 million in research funding.

Tamar Green, MD

PDO team was extremely responsive and professional. Working with PDO and RMG felt much more like teamwork, which greatly improved both the quality of the proposal and morale.

Tamar Green, MD, PI of NIH R01 "Neuropsychiatric and brain development trajectories in Ras-related syndrome, a longitudinal study"

Kyle Loh, PhD

It was a pleasure working together with the Proposal Development Office. Without the PDO's help, we definitely would not have been able to submit our consortium grant, that spanned six labs across two different institutions, on time. The team identified and resolved many issues that we were totally unaware of, and we were very grateful for the chance to work with them.

Kyle Loh, PhD, PI of AHA-AV “Discovering molecular mechanisms of Fontan resilience with human pluripotent stem cell-derived liver and lymphatic cells”


Shannon Stirman, PhD

The PDO team was wonderful to work with, and the resources and support they offered definitely had a positive impact on the quality of the proposal we put together.

Shannon Wiltsey Stirman, PhD, MPI of NIMH P50 "The Center for Responsible and Equitable AI-Based Technology Evolution"